Focus Partners Wealth’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$640K Buy
22,877
+4,743
+26% +$133K ﹤0.01% 1840
2026
Q1
$517K Sell
18,134
-43
-0.2% -$1.47K ﹤0.01% 1911
2025
Q4
$719K Sell
18,177
-1,703
-9% -$62.4K ﹤0.01% 1775
2025
Q3
$691K Buy
19,880
+1,824
+10% +$62.8K ﹤0.01% 1449
2025
Q2
$592K Buy
18,056
+7,779
+76% +$253K ﹤0.01% 1352
2025
Q1
$332K Sell
10,277
-6,029
-37% -$224K ﹤0.01% 1522
2024
Q4
$498K Buy
+16,306
New +$524K ﹤0.01% 1325
2024
Q3
– Sell
-16,140
Closed -$384K – 1580
2024
Q2
$384K Buy
16,140
+3,186
+25% +$73.5K ﹤0.01% 1008
2024
Q1
$321K Buy
+12,954
New +$434K ﹤0.01% 818

Other funds holding ATRC

Focus Partners Wealth's ATRC Position: Q2 2026 in Review

Focus Partners Wealth increased its AtriCure (ATRC) stake by 26% in Q2 2026, buying an estimated $133K and bringing the position to 22,877 shares worth $640K. The position accounts for ﹤0.01% of the portfolio, ranked #1840.

Focus Partners Wealth first reported a position in ATRC in Q1 2024 and has held it in 9 quarters since. The position peaked at $719K in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Focus Partners Wealth held 22,877 shares of AtriCure worth $640K as of Q2 2026.
  • Focus Partners Wealth bought 4,743 AtriCure shares in Q2 2026, an estimated $133K.
  • AtriCure made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #1840 holding.
  • Focus Partners Wealth first reported a position in AtriCure in Q1 2024 and has held it in 9 quarters since.
  • Focus Partners Wealth's AtriCure position peaked at $719K in Q4 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.